End in sight for Avecho as Phase III CBD trial moves into final stage by Adam Sheldon August 31, 2026August 31, 2026 Avecho Biotechnology has restarted recruitment for the final stage of its pivotal Phase III insomnia trial […]
Avecho recruits biotech exec to drive CBD global licensing push by Adam Sheldon August 24, 2026August 27, 2026
Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites by Steve Jones July 29, 2026July 30, 2026
Wait for CBD analysis was ‘torture’, says Avecho CEO as talks resume over licencing deals by Steve Jones July 9, 2026July 9, 2026
Avecho breathes ‘huge sigh of relief’ as early data points to successful CBD insomnia trial by Steve Jones June 24, 2026June 25, 2026
News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans by Adam Sheldon May 27, 2026June 8, 2026
News in brief: Avecho gains key patent allowances; Montu expands medical affairs team by Adam Sheldon December 9, 2025February 21, 2026
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
Sandoz over-the-counter CBD deal ‘remarkable’, Avecho chair tells AGM by Steve Jones May 28, 2025May 28, 2025
Avecho advances sleep trial following deal with European pharma giant by cannabiz team May 20, 2025May 20, 2025
